Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Human Health

Human HealthOur main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs.

Further reading »

Animal Health

Animal HealthAnimal Health develops and improves existing medical treatments focusing on oncology.

Further reading »

The Share

Latest News

Interim report for the period May - July 2015

September 3 2015
Oasmia has reclaimed the global distribution and sales rights for Paccal Vet and Doxophos Vet. Oasmia’s ongoing Nasdaq US listing, which was expected to close in August, has been extended. The closing is expected to be finalized in the near future.
Further reading »

Notice convening the Annual General Meeting of Oasmia Pharmaceutical AB

August 31 2015
The shareholders of Oasmia Pharmaceutical AB (publ), 556332-6676, are invited to participate in the Annual General Meeting to be held on Monday, September 28, 2015 at 2 p.m. at Vallongatan 1, Uppsala, Sweden. The registration will start at 1.30 p.m.
Further reading »

The Oasmia Pharmaceutiacal Annual Report is now published

August 21 2015
Further reading »